Blocking molecular target could make more cancers treatable with PARP inhibitors
Wednesday, June 29, 2011 - 14:30
in Health & Medicine
BOSTON--Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.